ROCKET PHARMACEUTICALS, INC. - 8-K Filing
Rocket Pharmaceuticals entered into a $150M loan agreement with Hercules Capital on September 30, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure)
Tickers: $RCKT